Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $108,236 | 57 | 95.8% |
| Food and Beverage | $3,265 | 48 | 2.9% |
| Travel and Lodging | $1,498 | 8 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kedplasma LLC | $108,236 | 57 | $0 (2024) |
| Abbott Laboratories | $1,687 | 21 | $0 (2024) |
| Relievant Medsystems, Inc. | $901.08 | 6 | $0 (2022) |
| Medtronic USA, Inc. | $506.97 | 11 | $0 (2020) |
| Nevro Corp. | $381.00 | 3 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $313.37 | 4 | $0 (2021) |
| Medtronic, Inc. | $231.24 | 4 | $0 (2022) |
| Saluda Medical Americas, Inc. | $147.65 | 1 | $0 (2021) |
| Arbor Pharmaceuticals, Inc. | $124.99 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $120.65 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,705 | 14 | Kedplasma LLC ($26,409) |
| 2023 | $49,664 | 33 | Kedplasma LLC ($48,592) |
| 2022 | $34,352 | 35 | Kedplasma LLC ($33,235) |
| 2021 | $952.71 | 13 | Abbott Laboratories ($323.30) |
| 2020 | $617.49 | 8 | Nevro Corp. ($381.00) |
| 2019 | $219.78 | 3 | Allergan Inc. ($118.93) |
| 2018 | $214.87 | 4 | Medtronic USA, Inc. ($214.87) |
| 2017 | $271.64 | 3 | Arbor Pharmaceuticals, Inc. ($124.99) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: Neuromodulation | ||||||
| 09/03/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $130.42 | General |
| Category: Neuromodulation | ||||||
| 08/30/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $1,909.09 | General |
| 07/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 06/28/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 05/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 04/30/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 04/03/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Neuromodulation | ||||||
| 03/29/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 02/29/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 02/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $45.65 | General |
| Category: Neuromodulation | ||||||
| 02/12/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $94.83 | General |
| Category: Neuromodulation | ||||||
| 02/12/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: Neuromodulation | ||||||
| 01/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 12/29/2023 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 11/30/2023 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 10/31/2023 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 09/29/2023 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $1,154.00 | General |
| 09/22/2023 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $2,346.00 | General |
| 09/08/2023 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $1,900.60 | General |
| 08/25/2023 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $2,019.60 | General |
| 08/11/2023 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $1,708.50 | General |
| 07/28/2023 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $1,679.60 | General |
| 07/19/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $66.50 | General |
| Category: Neuromodulation | ||||||
| 07/14/2023 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $2,094.40 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 16 | 19 | $7,220 | $1,705 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 19 | $7,220 | $1,705 | 23.6% |
About Dr. Daniel Beauchamp, DO
Dr. Daniel Beauchamp, DO is a Brain Injury Medicine healthcare provider based in Apo, AE. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2010. The National Provider Identifier (NPI) number assigned to this provider is 1336458207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Beauchamp, DO has received a total of $112,998 in payments from pharmaceutical and medical device companies, with $26,705 received in 2024. These payments were reported across 113 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($108,236).
As a Medicare-enrolled provider, Beauchamp has provided services to 16 Medicare beneficiaries, totaling 19 services with total Medicare billing of $1,705. Data is available for 1 year (2022–2022), covering 1 distinct procedure/service records.
Practice Information
- Specialty Brain Injury Medicine
- Other Specialties Pain Medicine, Physical Medicine & Rehabilitation
- Location Apo, AE
- Active Since 09/27/2010
- Last Updated 07/03/2024
- Taxonomy Code 2081P0301X
- Entity Type Individual
- NPI Number 1336458207
Products in Payments
- PROCLAIM (Device) $1,364
- Intracept (Device) $901.08
- Senza Spinal Cord Stimulation System (Device) $381.00
- Proclaim IPG (Device) $323.30
- KYPHON Balloon Kyphoplasty (Device) $311.89
- Superion (Device) $242.13
- INTELLIS (Device) $147.70
- ECAP Study (Device) $147.65
- Horizant (Drug) $124.99
- BELSOMRA (Drug) $120.65
- LIORESAL (Device) $119.68
- BOTOX (Drug) $118.93
- Nalu Neurostimulation System (Device) $113.63
- SPRINT PNS System (Device) $90.89
- GENERAL - PAIN MANAGEMENT (Device) $71.24
- MIDAS REX (Device) $54.52
- SYNCHROMEDII (Device) $40.70
- PERCEPT PC BRAINSENSE (Device) $34.59
- ACTIVA (Device) $26.00
- RESTORE (Device) $3.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.